Revenue | ₹984.49Cr |
Net Profits | ₹229.88Cr |
Net Profit Margins | 23.35% |
Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 18.13% since last year same period to ₹984.49Cr in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -6.24% fall in its revenue since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 402.8% since last year same period to ₹229.88Cr in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -8.96% fall in its net profits since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 325.62% since last year same period to 23.35% in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -2.9% fall in its net profit margins since last 3-months.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was ₹984.49Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was ₹229.88Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was 23.35%.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was ₹833.37Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was ₹45.72Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was 5.49%.